BML Capital Management, LLC — 13F Holdings & Portfolio
CIK 1616824 · latest 13F-HR filed 2026-08-07
BML Capital Management, LLC manages $176.1M in 13F-reported U.S. long-equity assets across 18 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are ACRS (35.98%), AVIR (18.36%), ENGN (6.55%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 1 new position and exited 1; 9 existing positions rose in reported value and 4 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-07
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
| Name | Title / Status | Ownership | Type |
|---|
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- ACLARIS THERAPEUTICS INC$9.9M +18.5%
- KRAFT HEINZ CO$8.2M +290.7%
- OUTSET MED INC$3.6M +49.0%
- CARMAX INC$2.7M +41.6%
- PMV PHARMACEUTICALS INC$545.4K +8.3%
Top Trims
- ORAMED PHARMACEUTICALS INC-$6.6M -61.3%
- ATEA PHARMACEUTICALS INC-$5.6M -14.9%
- INSTIL BIO INC-$355.1K -6.7%
- PLIANT THERAPEUTICS INC-$185.5K -9.5%
BML Capital Management, LLC Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | ACLARIS THERAPEUTICS INC | ACRS | 00461U105 | $63.3M | 35.98% | 11,975,000 | SH |
| 2 | ATEA PHARMACEUTICALS INC | AVIR | 04683R106 | $32.3M | 18.36% | 6,952,330 | SH |
| 3 | ENGENE THERAPEUTICS INC | ENGN | 29286X101 | $11.5M | 6.55% | 6,669,908 | SH |
| 4 | KRAFT HEINZ CO | KHC | 500754106 | $11.0M | 6.24% | 465,000 | SH |
| 5 | OUTSET MED INC | OM | 690145206 | $10.9M | 6.18% | 2,519,701 | SH |
| 6 | CARMAX INC | KMX | 143130102 | $9.1M | 5.18% | 172,500 | SH |
| 7 | TILLYS INC | TLYS | 886885102 | $9.0M | 5.13% | 2,150,000 | SH |
| 8 | PMV PHARMACEUTICALS INC | PMVP | 69353Y103 | $7.1M | 4.06% | 5,330,000 | SH |
| 9 | INSTIL BIO INC | TIL | 45783C200 | $5.0M | 2.82% | 645,600 | SH |
| 10 | TARGET CORP | TGT | 87612E106 | $4.9M | 2.78% | 37,500 | SH |
| 11 | ORAMED PHARMACEUTICALS INC | ORMP | 68403P203 | $4.2M | 2.37% | 866,269 | SH |
| 12 | JANUX THERAPEUTICS INC | JANX | 47103J105 | $2.4M | 1.35% | 154,961 | SH |
| 13 | PLIANT THERAPEUTICS INC | PLRX | 729139105 | $1.8M | 1.00% | 1,546,137 | SH |
| 14 | CONNECT BIOPHARMA HLDGS LTD | CNTB | G23549101 | $1.4M | 0.78% | 573,287 | SH |
| 15 | IMAGENEBIO INC | IMA | 45175G207 | $1.2M | 0.67% | 200,730 | SH |
| 16 | WALMART INC Put | WMT | 931142103 | $386.1K | 0.22% | 335 | SH |
| 17 | CORE SCIENTIFIC INC NEW Put | CORZ | 21874A106 | $298.0K | 0.17% | 800 | SH |
| 18 | TESLA INC Put | TSLA | 88160R101 | $270.0K | 0.15% | 375 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-07 | $176.1M | 18 | 0001754960-26-000696 |
| 2026-03-31 | 2026-05-06 | $155.8M | 16 | 0001754960-26-000359 |
| 2025-12-31 | 2026-02-03 | $115.7M | 16 | 0001754960-26-000146 |
ZIONSVILLE, IN 46077